| Trial ID: | L0049 |
| Source ID: | NCT02147925
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
|
| Acronym: |
LIGHT-ON
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Liraglutide combined with metformin|Drug: Insulin glargine combined with metformin|Drug: Sitagliptin combined with metformin
|
| Outcome Measures: |
Intrahepatic lipids (IHL)|Change of abdominal subcutaneous adipose tissue(SAT)|Change of visceral adipose tissue(VAT)|Change in hemoglobin A1c(HbA1c)
|
| Sponsor/Collaborators: |
Sun Yat-sen University
|
| Gender: |
All
|
| Age: |
30 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
75
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
August 2014
|
| Completion Date: |
April 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 18, 2018
|
| Locations: |
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT02147925
|
